The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2%

Tuesday, February 19, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Feb. 18, 2019 /PRNewswire/ -- The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market.

Download the full report: https://www.reportbuyer.com/product/5741674 The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million
by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.The infectious diseases segment held the largest share of the molecular controls market in 2018.Based on application, the molecular controls market is divided into four major segments—infectious diseases, oncology, genetic tests, and other applications.The infectious diseases segment accounted for the largest share of the molecular controls market in 2018.The large share of this segment is attributed to the development of advanced assays for different infectious diseases, significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.Asia Pacific projected to grow at the highest CAGR during the forecast period.The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the molecular quality controls market.•?By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%•?By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%•?By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The study includes an in-depth competitive analysis of these key players in the molecular quality controls market, along with their company profiles, recent developments, and key market strategies.Research Coverage:The market study covers the molecular quality controls market across various segments.It aims at estimating the market size and the growth potential of this market across different segments by product, analyte type, application, end user, and region.The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.Key Benefits of Buying the Report:The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall molecular quality controls market and its subsegments.This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies.The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.Download the full report: https://www.reportbuyer.com/product/5741674 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-molecular-quality-controls-market-is-expected-to-grow-from-usd-132-million-in-2018-to-usd-237-million-by-2024--at-a-cagr-of-10-2-300797365.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store